Miscellaneous Neoplasm - Solid Tumor

NCT06400238

Clinical Trial Information


Trial Number: NCT06400238 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Hematopoietic Neoplasm/Myeloma - Myeloma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol Z1H: Phase II Study of Copanlisib in Patients With Tumors With Deleterious PTEN Sequencing Result and PTEN Expression by IHC"
Study ID:
EAY131-Z1H
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT06360588

Clinical Trial Information


Trial Number: NCT06360588 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Hematopoietic Neoplasm/Myeloma - Myeloma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol Z1G: Phase II Study of Copanlisib in Patients With Tumors With PTEN Loss by IHC and Any PTEN Sequencing Result"
Study ID:
EAY131-Z1G
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03213678

Clinical Trial Information


Trial Number: NCT03213678 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis For Therapy Choice)- Phase 2 Subprotocol of LY3023414 in Patients With Solid Tumors"
Study ID:
APEC1621D
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03526250

Clinical Trial Information


Trial Number: NCT03526250 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients With Tumors Harboring Activating Alterations in Cell Cycle Genes"
Study ID:
APEC1621I
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03220035

Clinical Trial Information


Trial Number: NCT03220035 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Vemurafenib in Patients With Tumors Harboring BRAF V600 Mutations"
Study ID:
APEC1621G
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03233204

Clinical Trial Information


Trial Number: NCT03233204 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- A Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes"
Study ID:
APEC1621H
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT06385483

Clinical Trial Information


Trial Number: NCT06385483 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol A: Phase II Trial of Afatinib in Patients With Solid Tumors (Other Than Small Cell and Non-Small Cell Lung Cancer) or Lymphomas, That Have Activating Mutations of EGFR and Have Progressed After Standard Treatment"
Study ID:
EAY131-A
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT00924651

Clinical Trial Information


Trial Number: NCT00924651 (ClinicalTrials.gov)
Disease Type:
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"A Study of the Effects of Exercise on Cancer-Related Fatigue"
Study ID:
URCC-0701
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT06136897

Clinical Trial Information


Trial Number: NCT06136897 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol J: Trastuzumab and Pertuzumab (HP) in Patients With Non-Breast, Non-Gastric/GEJ, and Non-Colorectal Cancers With HER2 Amplification"
Study ID:
EAY131-J
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03698994

Clinical Trial Information


Trial Number: NCT03698994 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (Ulixertinib) in Patients With Tumors Harboring Activating MAPK Pathway Mutations"
Study ID:
APEC1621J
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Subscribe to Miscellaneous Neoplasm - Solid Tumor

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®